SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
PAPADOPOULOS STELIOS

(Last) (First) (Middle)
BIOGEN INC.
225 BINNEY STREET

(Street)
CAMBRIDGE MA 02142

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BIOGEN INC. [ BIIB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/12/2018
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/12/2018 A 1,450 A $0 3,190(1)(2) D
Common Stock 10,831(1) I Esperanza Holdings, LLC
Common Stock 17,375(2) I Stelios Holdings, LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reporting person transferred 5,831 shares that he directly owned to Esperanza Holdings, LLC.
2. The reporting person transferred 12,375 shares that he directly owned to Stelios Holdings, LLC.
Suzanne Murray, Attorney in Fact for Stelios Papadopoulos 06/14/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS


	Know all by these presents, that the undersigned hereby makes, 
constitutes and appoints Susan H. Alexander, James Basta, Marcia J. 
Gookin and Suzanne Murray as the undersigned's true and lawful 
attorney-in-fact, with full power and authority as hereinafter described
on behalf of and in the name, place and stead of the undersigned to:

(1)	prepare, execute in the undersigned?s name and on the undersigned?s
 behalf, and submit to the U.S. Securities and Exchange Commission 
(the ?SEC?) a Form ID, including amendments thereto, and any other documents 
necessary or appropriate to obtain codes and passwords enabling the 
undersigned to make electronic filings with the SEC of reports required
by Section 16(a) of the Securities Exchange Act of 1934 and the rules and
regulations promulgated thereunder, as amended from time to time (the 
"Exchange Act"), or any rule or regulation of the SEC;

(2)	prepare, execute, acknowledge, deliver and file Forms 3, 4, 
and 5 (including any amendments thereto) with respect to the securities
of Biogen Inc., a Delaware corporation (the "Company"), with the SEC,
any national securities exchanges and the Company, as considered necessary 
or advisable
 under Section 16(a) of the Exchange Act;

(3)	seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information on transactions in the Company's 
securities from any third party, including brokers, employee benefit 
plan administrators and trustees, and the undersigned hereby authorizes
any such person to release any such information to the undersigned and 
approves and ratifies any such release of information; and

(4)	perform any and all other acts which in the discretion of such 
attorney-in-fact are necessary or desirable for and on behalf of the 
undersigned in connection with the foregoing.

The undersigned acknowledges that:

(A)	this Limited Power of Attorney authorizes, but does not require,
such attorney-in-fact to act in their discretion on information provided
to such attorney-in-fact without independent verification of such 
information;

(B)	any documents prepared and/or executed by such attorney-in-fact
on behalf of the undersigned pursuant to this Limited Power of Attorney
will be in such form and will contain such information and disclosure 
as such attorney-in-fact, in his or her discretion, deems necessary or 
desirable;

(C)	neither the Company nor such attorney-in-fact assumes (i) any
liability for the undersigned's responsibility to comply with the 
requirement of the Exchange Act, (ii) any liability of the undersigned
for any failure to comply with such requirements, or (iii) any obligation
or liability of the undersigned for profit disgorgement under Section 16(b)
of the Exchange Act; and

(D)	this Limited Power of Attorney does not relieve the undersigned
from responsibility for compliance with the undersigned's obligations 
under the Exchange Act, including without limitation the reporting 
requirements under Section 16 of the Exchange Act.

	The undersigned hereby gives and grants the foregoing
attorney-in-fact full power and authority to do and perform all 
and every act and thing whatsoever requisite, necessary or appropriate
to be done in and about the foregoing matters as fully to all intents 
and purposes as the undersigned might or could do if present, hereby 
ratifying all that such attorney-in-fact of, for and on behalf of 
the undersigned, shall lawfully do or cause to be done by virtue of 
this Limited Power of Attorney.

	This Limited Power of Attorney shall remain in full force 
and effect until revoked by the undersigned in a signed writing 
delivered to such attorney-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Limited 
Power of Attorney to be executed as of this 15th day of January, 2018.
 
                                        _/s/ Stelios Papadopoulos__
					Signature

					Name:  Stelios Papadopoulos